Global Alliance for Genomics and Health

Last updated

The Global Alliance for Genomics and Health (GA4GH) is an international consortium that is developing standards for responsibly collecting, storing, analyzing, and sharing genomic data in order to enable an "internet of genomics". [1] [2] GA4GH was founded in 2013. [3]

Contents

GA4GH is founded on the Framework for the Responsible Sharing of Genomic and Health-related Data, [4] which is based on the human right to benefit from scientific advances. [5]

Organization

GA4GH maintained by four Host Institutions (Wellcome Sanger Institute, Broad Institute, Ontario Institute for Cancer Research and the European Bioinformatics Institute). [6] Heidi Rehm is the current GA4GH chair [7] and Peter Goodhand is the Chief Executive Officer. [8] Kathryn North is the current Vice Chair and Ewan Birney is the past chair. [9]

Organizational members of the alliance include: [6]

Funding

GA4GH is supported by a "Funder's Forum" composed of organizations whose funding commitments exceed USD $200,000 annually, for at least three years. Forum members include: [6]

Activities

All GA4GH standards are developed by six technical and two foundational "Work Streams" in collaboration with real-world genomic data initiatives called "Driver Projects." [8]

GA4GH Work Streams

  1. Regulatory and Ethics (foundational) [7]  
  2. Data Security (foundational) [7]  
  3. Cloud Archived 2020-10-04 at the Wayback Machine [7]  
  4. Clinical & Phenotypic Data Capture [7]  
  5. Data Use and Researcher Identities [7]  
  6. Discovery Archived 2018-10-26 at the Wayback Machine [7]  
  7. Genomic Knowledge Standards [7]  
  8. Large Scale Genomics Archived 2020-09-21 at the Wayback Machine [7]  

GA4GH Driver Projects

  1. All of US Research Program [3]
  2. Australian Genomics [3]
  3. BRCA Challenge [3]
  4. Canadian Distributed Infrastructure for Genomics (CanDig) [3]
  5. Clinical Genome Resource (ClinGen) [3]
  6. ELIXIR Beacon [3]
  7. The European Nucleotide Archive, European Variation Archive, and European Genome-phenome Archive at EMBL-EBI [3]
  8. EUCANCan [10]
  9. European Joint Programme on Rare Diseases [11]
  10. Genomics England [12]
  11. Human Cell Atlas [12]
  12. Human Heredity and Health in Africa (H3Africa) [13]
  13. International Cancer Genome Consortium - ARGO [12]
  14. Matchmaker Exchange [12]
  15. The Monarch Initiative [12]
  16. National Cancer Institute Data Commons Framework (NCI DCF) and Genomic Data Commons (NCI GDC) [12]
  17. Trans-Omics for Precision Medicine (TOPMed) [12]
  18. Variant Interpretation for Cancer Consortium (VICC) Archived 2021-11-19 at the Wayback Machine [12]

Genomic Beacon API

The Genomic Beacon API is a standard of GA4GH. [14] The "Beacon" protocol was originally proposed as a simple standard for the discovery of genomic sequence variants using federated queries against a potentially large number of genomic databases with implicit security provided through the use of limited query parameters and restriction to Boolean responses. In the version 2 of the protocol the API supports "phenoclinical" queries (e.g. combining parameters for genomic variant discovery with diagnostic or technical parameters) as well as responses containing versions of the matched records.

Related Research Articles

<span class="mw-page-title-main">Bioinformatics</span> Computational analysis of large, complex sets of biological data

Bioinformatics is an interdisciplinary field of science that develops methods and software tools for understanding biological data, especially when the data sets are large and complex. Bioinformatics uses biology, chemistry, physics, computer science, computer programming, information engineering, mathematics and statistics to analyze and interpret biological data. The subsequent process of analyzing and interpreting data is referred to as computational biology.

<span class="mw-page-title-main">BGI Group</span> Chinese genome sequencing company

BGI Group, formerly Beijing Genomics Institute, is a Chinese genomics company with headquarters in Yantian, Shenzhen. The company was originally formed in 1999 as a genetics research center to participate in the Human Genome Project. It also sequences the genomes of other animals, plants and microorganisms.

<span class="mw-page-title-main">Marco Marra</span> Canadian geneticist

Marco A. Marra is a Distinguished Scientist and Director of Canada's Michael Smith Genome Sciences Centre at the BC Cancer Research Centre and Professor of Medical Genetics at the University of British Columbia (UBC). He also serves as UBC Canada Research Chair in Genome Science for the Canadian Institutes of Health Research and is an inductee in the Canadian Medical Hall of Fame. Marra has been instrumental in bringing genome science to Canada by demonstrating the pivotal role that genomics can play in human health and disease research.

<span class="mw-page-title-main">University of Toronto Faculty of Medicine</span> Medical school of the University of Toronto

The Temerty Faculty of Medicine is the medical school of the University of Toronto. Founded in 1843, the faculty is based in Downtown Toronto and is one of Canada's oldest institutions of medical studies, being known for the discovery of insulin, stem cells and the site of the first single and double lung transplants in the world.

<span class="mw-page-title-main">Wellcome Sanger Institute</span> British genomics research institute

The Wellcome Sanger Institute, previously known as The Sanger Centre and Wellcome Trust Sanger Institute, is a non-profit British genomics and genetics research institute, primarily funded by the Wellcome Trust.

<span class="mw-page-title-main">George Church (geneticist)</span> American geneticist

George McDonald Church is an American geneticist, molecular engineer, chemist, serial entrepreneur, and pioneer in personal genomics and synthetic biology. He is the Robert Winthrop Professor of Genetics at Harvard Medical School, Professor of Health Sciences and Technology at Harvard University and Massachusetts Institute of Technology, and a founding member of the Wyss Institute for Biologically Inspired Engineering at Harvard University.

<span class="mw-page-title-main">Ewan Birney</span> English businessman

John Frederick William Birney is joint director of EMBL's European Bioinformatics Institute (EMBL-EBI), in Hinxton, Cambridgeshire and deputy director general of the European Molecular Biology Laboratory (EMBL). He also serves as non-executive director of Genomics England, chair of the Global Alliance for Genomics and Health (GA4GH) and honorary professor of bioinformatics at the University of Cambridge. Birney has made significant contributions to genomics, through his development of innovative bioinformatics and computational biology tools. He previously served as an associate faculty member at the Wellcome Trust Sanger Institute.

<span class="mw-page-title-main">Human Genome Project</span> International scientific research project

The Human Genome Project (HGP) was an international scientific research project with the goal of determining the base pairs that make up human DNA, and of identifying, mapping and sequencing all of the genes of the human genome from both a physical and a functional standpoint. It started in 1990 and was completed in 2003. It remains the world's largest collaborative biological project. Planning for the project started after it was adopted in 1984 by the US government, and it officially launched in 1990. It was declared complete on April 14, 2003, and included about 92% of the genome. Level "complete genome" was achieved in May 2021, with only 0.3% of the bases covered by potential issues. The final gapless assembly was finished in January 2022.

The Baylor College of Medicine Human Genome Sequencing Center (BCM-HGSC) was established by Richard A. Gibbs in 1996 when Baylor College of Medicine was chosen as one of six worldwide sites to complete the final phase of the international Human Genome Project. Gibbs is the current director of the BCM-HGSC.

The International Cancer Genome Consortium (ICGC) is a voluntary scientific organization that provides a forum for collaboration among the world's leading cancer and genomic researchers. The ICGC was launched in 2008 to coordinate large-scale cancer genome studies in tumours from 50 cancer types and/or subtypes that are of main importance across the globe.

<span class="mw-page-title-main">Whole genome sequencing</span> Determining nearly the entirety of the DNA sequence of an organisms genome at a single time

Whole genome sequencing (WGS) is the process of determining the entirety, or nearly the entirety, of the DNA sequence of an organism's genome at a single time. This entails sequencing all of an organism's chromosomal DNA as well as DNA contained in the mitochondria and, for plants, in the chloroplast.

Knome, Inc. was a human genome interpretation company based in Cambridge, Massachusetts. Launched in 2007, Knome focused on improving quality of life by applying insights gained from the interpretation of human genomes. They helped identify and classify the variants, genes, and gene sets that are likely to govern or underlie a specific disease, tumor, or drug response. Their clients included academic, pharmaceutical and medical researchers. In 2015, it was acquired by Tute Genomics.

John Quackenbush is an American computational biologist and genome scientist. He is a professor of biostatistics and computational biology and a professor of cancer biology at the Dana–Farber Cancer Institute (DFCI), as well as the director of its Center for Cancer Computational Biology (CCCB). Quackenbush also holds an appointment as a professor of computational biology and bioinformatics in the Department of Biostatistics at the Harvard School of Public Health.

Philip Awadalla is a professor of medical and population genetics at the Ontario Institute for Cancer Research, and the Department of Molecular Genetics, Faculty of Medicine, University of Toronto. He is the National Scientific Director of the Canadian Partnership for Tomorrow's Health (CanPath), formerly the Canadian Partnership for Tomorrow Project (CPTP), and executive director of the Ontario Health Study. He is also the Executive Scientific Director of the Genome Canada Genome Technology Platform, the Canadian Data Integration Centre. Professor Awadalla was the Executive Scientific Director of the CARTaGENE biobank, a regional cohort member of the CPTP, from 2009 to 2015, and is currently a scientific advisor for this and other scientific and industry platforms. At the OICR, he is Director of Computational Biology.

The International Human Epigenome Consortium (IHEC) is a scientific organization, founded in 2010, that helps to coordinate global efforts in the field of Epigenomics. The initial goal was to generate at least 1,000 reference (baseline) human epigenomes from different types of normal and disease-related human cell types.

The UC Santa Cruz Genomics Institute is a public research institution based in the Jack Baskin School of Engineering at the University of California, Santa Cruz. The Genomics Institute's scientists and engineers work on a variety of projects related to genome sequencing, computational biology, large data analytics, and data sharing. The institute also maintains a number of software tools used by researchers worldwide, including the UCSC Genome Browser, Dockstore, and the Xena Browser.

Charmaine DM Royal is an American geneticist and Associate Professor at the Institute for Genome Sciences & Policy and the Department of African and African American Studies at Duke University. She studies the intersections of race, ethnicity, ancestry genetics, and health, especially as they pertain to historically marginalized and underrepresented groups in genetic and genomic research; and genomics and global health. Her major interest is in addressing root causes and implementing sustainable solutions regarding problems of race and racism in research, healthcare, and society. Royal is a Human Heredity and Health in Africa (H3Africa) Independent Expert Committee (IEC) member appointed by the National Institutes of Health (NIH) and is a 2020 Ida Cordelia Beam Distinguished Visiting Professor at the University of Iowa.

Human Heredity and Health in Africa, or H3Africa, is an initiative to study the genomics and medical genetics of African people. Its goals are to build the continent's research infrastructure, train researchers and clinicians, and to study questions of scientific and medical interest to Africans. The H3Africa Consortium was formally launched in 2012 in Addis Ababa and has grown to include research projects across 32 countries, a pan-contintental bioinformatics network, and the first whole genome sequencing of many African ethnolinguistic groups.

<span class="mw-page-title-main">African Society of Human Genetics</span>

The African Society of Human Genetics (AfSHG) is a learned society and professional membership organization focused on the study of human genetics and genomics in Africans, and open to researchers who are interested in the subject. It has played a role in founding several national genetics societies, and is affiliated with the societies of Cameroon, the Democratic Republic of the Congo, Mali, Egypt, Rwanda, Senegal, South Africa, and Tanzania.

References

  1. ↑ Regalado, Antonio. "Networks of Genome Data Will Transform Medicine". MIT Technology Review. Archived from the original on 2018-11-09. Retrieved 2018-10-23.
  2. ↑ Salisbury, Meredith. "The IoT Of Health: Big Data Can Make Us Healthier". Forbes. Archived from the original on 2018-10-26. Retrieved 2018-10-23.
  3. 1 2 3 4 5 6 7 8 Petrone, Justin (October 17, 2017). "Global Alliance for Genomics and Health Releases Strategic Plan, Announces Driver Projects". GenomeWeb. Archived from the original on 2018-10-26. Retrieved 2018-10-24.
  4. ↑ Scialom, Mike. "A RAREfest insight into genetic medicine". Cambridge Independent. Archived from the original on 2018-10-26. Retrieved 2018-10-23.
  5. ↑ "Article 27". www.claiminghumanrights.org (in German). Archived from the original on 2018-10-08. Retrieved 2018-10-23.
  6. 1 2 3 "Funders and sponsors". GA4GH. Archived from the original on 2022-02-09. Retrieved 2022-11-20.
  7. 1 2 3 4 5 6 7 8 9 Raths, David (February 7, 2018). "Global Alliance for Genomics and Health Launches Ambitious Roadmap". Healthcare Informatics Magazine. Archived from the original on 2018-10-26. Retrieved 2018-10-23.
  8. 1 2 Ross, Benjamin (February 26, 2018). "GA4GH Releases 2018 Strategic Roadmap". www.bio-itworld.com. Archived from the original on 2018-10-26. Retrieved 2018-10-24.
  9. ↑ "Bio-IT World". www.bio-itworld.com. Archived from the original on 2024-02-17. Retrieved 2019-01-16.
  10. ↑ "EUCANCan". eucancan.com. Archived from the original on 2022-03-20. Retrieved 2022-03-24.
  11. ↑ "European Joint Programme on Rare Diseases". www.ejprarediseases.org. Archived from the original on 2022-03-28. Retrieved 2022-03-24.
  12. 1 2 3 4 5 6 7 8 Proffitt, Allison (October 17, 2017). "GA4GH Announces New Strategic Plan, Vision To Create Standards". www.bio-itworld.com. Archived from the original on 2018-12-08. Retrieved 2018-10-24.
  13. ↑ "H3Africa". h3africa.org. Archived from the original on 2022-03-24. Retrieved 2022-03-24.
  14. ↑ Rambla, Jordi; Michael Baudis; Roberto Ariosa; Tim Beck; Lauren A. Fromont; Arcadi Navarro; Rahel Paloots; Manuel Rueda; Gary Saunders; Babita Singh; John D. Spalding; Juha Törnroos; Claudia Vasallo; Colin D. Veal; Anthony J. Brookes (17 March 2022). "Beacon v2 and Beacon networks: A "lingua franca" for federated data discovery in biomedical genomics, and beyond". Human Mutation. 43 (6): 791. Archived from the original on 18 March 2024. Retrieved 24 March 2024.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.